In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer.

MLA

Chang, Chao-Di, et al. “In Silico Identification and Biological Evaluation of a Selective MAP4K4 Inhibitor against Pancreatic Cancer.” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 38, no. 1, Dec. 2023, p. 2166039. EBSCOhost, https://doi.org/10.1080/14756366.2023.2166039.

APA

Chang, C.-D., Chao, M.-W., Lee, H.-Y., Liu, Y.-T., Tu, H.-J., Lien, S.-T., Lin, T. E., Sung, T.-Y., Yen, S.-C., Huang, S.-H., Hsu, K.-C., & Pan, S.-L. (2023). In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. Journal of Enzyme Inhibition and Medicinal Chemistry, 38(1), 2166039. https://doi.org/10.1080/14756366.2023.2166039

Chicago

Chang, Chao-Di, Min-Wu Chao, Hsueh-Yun Lee, Yi-Ting Liu, Huang-Ju Tu, Ssu-Ting Lien, Tony Eight Lin, et al. 2023. “In Silico Identification and Biological Evaluation of a Selective MAP4K4 Inhibitor against Pancreatic Cancer.” Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1): 2166039. doi:10.1080/14756366.2023.2166039.